Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Abbott Laboratories (ABT) had Weighted-Average Shares Outstanding (Diluted) of 1.74B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$12.59B |
|
$928.00M |
|
$5.33B |
|
$7.27B |
|
$10.90B |
|
$1.69B |
|
$-169.00M |
|
$1.52B |
|
$1.52B |
|
$928.00M |
|
$928.00M |
|
$928.00M |
|
$928.00M |
|
$1.69B |
|
$2.75B |
|
1.74B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.74B |
$0.53 |
|
$0.53 |
|
| Balance Sheet Financials | |
$24.52B |
|
$12.81B |
|
$84.70B |
|
$109.22B |
|
$17.81B |
|
$29.60B |
|
$39.64B |
|
$57.45B |
|
$51.76B |
|
$-693.00M |
|
$51.76B |
|
1.73B |
|
| Cash Flow Statement Financials | |
$3.80B |
|
$-21.00B |
|
$13.79B |
|
$8.52B |
|
$5.10B |
|
$-3.42B |
|
$485.00M |
|
$-2.20B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.38 |
|
-- |
|
-- |
|
0.36 |
|
0.63 |
|
57.71% |
|
13.44% |
|
13.44% |
|
-- |
|
12.10% |
|
7.37% |
|
$2.91B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.73 |
|
1.46 |
|
61.46 |
|
1.79% |
|
-133.91% |
|
0.85% |
|
1.14% |
|
$29.91 |
|
$1.67 |
|
$2.18 |
|